๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Liver transplantation for sclerosing cholangitis

โœ Scribed by Shunji Narumi; John P. Roberts; Jean C. Emond; John Lake; Nancy L. Ascher

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
768 KB
Volume
22
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pediatric liver transplantation for prim
Pediatric liver transplantation for primary sclerosing cholangitis
โœ Tamir Miloh; Ravinder Anand; Wendy Yin; Miriam Vos; Nanda Kerkar; Estella Alonso ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 241 KB ๐Ÿ‘ 2 views

Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease in children. The aim of this study was to determine the characteristics and outcomes of children with PSC who were listed for liver transplantation (LT). Children who underwent transplantation for PSC according to the Studies o

Biliary malignancies in primary sclerosi
Biliary malignancies in primary sclerosing cholangitis: Timing for liver transplantation
โœ B Nashan; H J Schlitt; G Tusch; K J Oldhafer; B Ringe; S Wagner; R Pichlmayr ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 204 KB ๐Ÿ‘ 2 views

is suggested, and transplantation should be taken into Primary sclerosing cholangitis (PSC) is a chronic inconsideration at scores above 4. (HEPATOLOGY 1996; flammatory disease associated in 10% to 36% of those 23:1105-1111.) with hepatobiliary malignancies, which are, in the majority of cases, not

Risk factors for recurrence of primary s
Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation
โœ Evangelos Cholongitas; Vibhakorn Shusang; George V. Papatheodoridis; Laura Marel ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 94 KB ๐Ÿ‘ 2 views

Liver transplantation (LT) is the only therapeutic option for end-stage primary sclerosing cholangitis (PSC), but PSC can recur (rPSC) in some patients after LT. The aim of our study was to evaluate the risk factors associated with rPSC. Between 1989 and 2004, 69 patients receiving transplantation f

Risk factors for recurrence of primary s
Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation
โœ Jacob Alexander; James D. Lord; Matthew M. Yeh; Carlos Cuevas; Ramasamy Bakthava ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 123 KB ๐Ÿ‘ 2 views

Orthotopic liver transplantation (OLT) is the only effective treatment for end-stage liver disease due to primary sclerosing cholangitis (PSC). Recurrence of PSC has recently emerged as a leading cause of allograft failure in the long term. There is limited data on risk factors for recurrence of PSC

Long-term results of patients undergoing
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis
โœ Ivo W. Graziadei; Russell H. Wiesner; Paul J. Marotta; Michael K. Porayko; J. Ei ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 102 KB ๐Ÿ‘ 2 views

Liver transplantation is the only effective therapeutic option for patients with end-stage liver disease due to primary sclerosing cholangitis (PSC). In this study, we analyzed a single center's experience with 150 consecutive PSC patients who received 174 liver allografts. Mean follow-up was 55 mon